2008-03-18 News Blaze
Newswise - The gene for the HDL-associated protein paraoxonase 1 (PON1) appears to be associated with coronary artery disease and with the risk of developing adverse cardiac events, and variations in both the PON1 gene and its related enzyme activity may increase the risk for cardiovascular disease...
2008-03-18 Journal of the American Medical Association
Advances in genetics and genomics are revolutionizing biomedical science and providing great promise for the future of clinical practice. The magnitude, scope, and pace of discovery in genetics and genomics research are at unprecedented levels and continue to increase...
2008-03-18 Journal of the American Medical Association
Context Paraoxonase 1 (PON1) is reported to have antioxidant and cardioprotective properties. The relationship between PON1 genotypes and functional activity with systemic measures of oxidative stress and cardiovascular disease (CVD) risk in humans has not been systematically...
2008-03-18 Medical News Today
Visitor Ratings: Healthcare Professional: General Public: rate this article A new study published in the Journal of the American Medical Association reports that there is an association between the gene for the HDL-associated protein paraoxonase 1 (PON1) and adverse cardiac events such as coronary..
2008-03-16 NewsRX
Research findings, 'Lipid peroxidation in stroke patients,' are discussed in a new report. According to a study from Ancona, Italy, 'Paraoxonase is high-density lipoprotein (HDL)-associated esterase/lactonase implicated to play a role in the and properties exerted by...
2008-03-12 Army Times
A scientists review of Gulf War illness studies shows that many of the symptoms including chronic fatigue, pain and cognitive problems can be explained by similar chemicals used in pesticides, sarin gas and anti-nerve-agent...
2008-03-12 South Asian Womens Forum
There is increasing evidence of exposure to certain chemicals, including pesticides and nerve agents causing high rates of illness in Persian Gulf War...
2008-03-11 Innovations-Report
UCSD researchers warn of potential risk to civilians exposed to...
2008-03-04 Medical News Today
Visitor Ratings: Healthcare Professional: General Public: rate this article Randox Laboratories has produced a biochip screening test for growth promoter drug residues including Beta-Agonists, Corticosteroids, Stilbenes and Ractopamine.
2008-03-02 Medical News Today
Visitor Ratings: Healthcare Professional: General Public: rate this article Randox has developed a biochip for the early detection of myocardial infarction (MI), more commonly known as heart...